Published in Hepatology on October 01, 1992
Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci (2011) 1.50
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat (2011) 1.24
Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Am J Pathol (1996) 1.04
Autoantibody-negative autoimmune hepatitis. Dig Dis Sci (2011) 1.03
Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci (2010) 1.01
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis (2004) 0.94
Autoimmune hepatitis--approach to diagnosis. MedGenMed (2006) 0.92
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut (1998) 0.89
Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut (1995) 0.83
Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis. J Immunol Res (2015) 0.81
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut (1998) 0.79
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis (2012) 0.79
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis (2007) 0.78
Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Dig Dis Sci (2017) 0.77
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver (2016) 0.77
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci (2015) 0.77
Argininosuccinate lyase: a new autoantigen in liver disease. Clin Exp Immunol (1998) 0.76
Novel Immunotherapies for Autoimmune Hepatitis. Front Pediatr (2017) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion (2000) 2.42
Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology (1993) 1.71
On the action of precipitated insulin administered by mouth. J Physiol (1931) 1.66
Estimating the prevalence of anaemia: a comparison of three methods. Bull World Health Organ (2001) 1.62
Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr (1990) 1.61
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol (2000) 1.58
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod (2005) 1.58
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A (1988) 1.57
High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants. J Viral Hepat (2011) 1.55
Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med (1985) 1.52
A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol (1978) 1.49
Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology (1983) 1.48
Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol (1993) 1.39
Pooling plasmas for a rapid answer in pharmacokinetic studies: application to a bioequivalence study of hydrocortisone tablets. Fundam Clin Pharmacol (1993) 1.39
Chronic active hepatitis associated with liver-kidney microsomal antibody of an autoimmune type. Two familial cases. Dig Dis Sci (1986) 1.39
[Idiopathic portal hypertension associated with connective tissue disease similar to systemic lupus erythematosus]. Gastroenterol Clin Biol (1989) 1.39
Acute renal failure after rifampicin. Lancet (1972) 1.36
Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol (1974) 1.33
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol (1984) 1.25
Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet (1981) 1.21
[Quantitative estimate of the risk of blood donation contamination by infectious agents]. Transfus Clin Biol (2009) 1.21
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology (1988) 1.21
Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online (2008) 1.21
Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur J Clin Microbiol Infect Dis (2001) 1.21
Sensitivity to rifampicin: incidence, mechanism, and prevention. Br Med J (1974) 1.20
Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr (1986) 1.19
A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol (1982) 1.17
A peripheral protein associated with the cis-Golgi network redistributes in the intermediate compartment upon brefeldin A treatment. J Cell Biol (1994) 1.16
High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. BMJ (1994) 1.16
Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr (1993) 1.15
The potential of various foods to serve as a carrier for micronutrient fortification, data from remote areas in Indonesia. Eur J Clin Nutr (2000) 1.13
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A (1987) 1.10
Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev (2011) 1.08
Serological arguments for classifying Raynaud's phenomenon as idiopathic. J Rheumatol (1990) 1.08
[Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment]. Nouv Presse Med (1975) 1.07
Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol (2007) 1.06
Blood safety and nucleic acid testing in Europe. Euro Surveill (2005) 1.06
Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology (1999) 1.05
A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav (1984) 1.05
Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med (1974) 1.03
Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers. Arzneimittelforschung (1993) 1.03
[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)]. Transfus Clin Biol (2004) 1.03
Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology (1985) 1.03
West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. Euro Surveill (2010) 1.01
Detection of West Nile virus infection in horses, Italy, September 2008. Euro Surveill (2008) 1.01
Comparison of gonosomal aneuploidy in spermatozoa of normal fertile men and those with severe male factor detected by in-situ hybridization. Mol Hum Reprod (1997) 1.00
Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families. Medicine (Baltimore) (2001) 0.99
Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5. Hum Reprod (2004) 0.98
A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin Exp Immunol (1997) 0.98
Parental origin of chromatin in human monopronuclear zygotes revealed by asymmetric histone methylation patterns, differs between IVF and ICSI. Mol Reprod Dev (2009) 0.98
The effect of tetanus toxin on the choline esterase activity of the muscles of rats. J Physiol (1939) 0.97
[New immunologic classification of the hemolytic anemias with autoantibodies]. Nouv Rev Fr Hematol (1968) 0.97
Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology (1999) 0.96
Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America. J Viral Hepat (1995) 0.94
[Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin]. Rev Tuberc Pneumol (Paris) (1973) 0.94
Bactericidal intraprostatic concentrations of norfloxacin. Lancet (1983) 0.93
A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang (2014) 0.92
Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet (1985) 0.92
[Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003]. Transfus Clin Biol (2005) 0.92
Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology (1996) 0.92
Organophosphorus and carbamate pesticide analysis using an inhibition tyrosinase organic phase enzyme sensor; comparison by butyrylcholinesterase+choline oxidase opee and application to natural waters. Anal Chim Acta (2007) 0.90
Perioperative antibiotic prophylaxis: improved compliance and impact on infection rates. Epidemiol Infect (2010) 0.90
[Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)]. Nouv Presse Med (1980) 0.89
Autoantibodies in D-penicillamine treated rheumatoid arthritis. Agents Actions (1976) 0.89
FISH analysis of 15 chromosomes in human day 4 and 5 preimplantation embryos: the added value of extended aneuploidy detection. Prenat Diagn (2007) 0.89
Detection of autoantibodies to Sm antigen in systemic lupus erythematosus by immunodiffusion, ELISA and immunoblotting: variability of incidence related to assays and ethnic origin of patients. Eur J Clin Invest (1990) 0.89
Polyploidy in malignant melanoma. Cancer (1970) 0.88
Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler (2007) 0.87
Capsule contraction after continuous curvilinear capsulorhexis. J Cataract Refract Surg (1996) 0.87
Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases. Ann Biol Clin (Paris) (1987) 0.87
Tyrosinase inhibition organic phase biosensor for triazinic and benzotriazinic pesticide analysis (part two). Anal Bioanal Chem (2005) 0.87
Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill (2005) 0.87
High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation (1998) 0.87
Abnormal anti-single stranded (ss) DNA activity in sera from Plasmodium falciparum infected individuals. Trans R Soc Trop Med Hyg (1984) 0.86
Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol (1994) 0.86
Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheumatol (1992) 0.86
Profile of memory impairment and gray matter loss in amnestic mild cognitive impairment. Neuropsychologia (2007) 0.85
Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment. Cancer Res (1994) 0.85
Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry (2002) 0.85
Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost (1997) 0.85
Antioxidant capacity of the algae using a biosensor method. Talanta (2005) 0.85
[Immunological anomalies observed during hyperlymphocytic chronic lymphoid leukemia]. Nouv Rev Fr Hematol (1972) 0.84
Measures to prevent transfusion-associated protozoal infections in non-endemic countries. Travel Med Infect Dis (2006) 0.84
Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients. Transplantation (1985) 0.84
Pharmacokinetics of cefotaxime in preterm infants. Dev Pharmacol Ther (1990) 0.84
Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. Haemostasis (1999) 0.84
Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre. Nephrol Dial Transplant (1999) 0.83
Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transpl (2001) 0.83